关于瘤学综合基因组分析政策的相关因素:利益相关方的观点
Lucas Frederik van Schaik1, Ellen Gurumay Engelhardt1, Wim Herbert van Harten1,2
1Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, P.O. Box 90203, Amsterdam, 1006 BE, The Netherlands.
综合基因组分析 (CGP) 提供了新的癌症治疗选择,但它的价值仍在争论中. 利益相关者优先考虑诊断影响,可行性和患者的旅程,以及决策的成本和临床益处.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 卫生技术评估 卫生技术评估
背景情况:
- 综合基因组分析 (CGP) 通过识别新的治疗点,有助于个性化癌症管理.
- 对CGP研究所需的复杂性和投资造成了对其整体价值的不确定性.
- 临床效益和成本效益是CGP覆盖决策的主要驱动因素.
研究的目的:
- 评估CGP技术评估中的五个额外因素的重要性.
- 这些因素包括可行性,患者/医生测试旅程,诊断含义,实验室组织和科学溢出.
- 该研究旨在了解利益相关者对这些因素的看法,以便明智作出决策.
主要方法:
- 有目的的抽样确定了来自荷兰医疗,分子,患者和决策者团体的利益相关者.
- 半结构面试评估了五个因素 (0-5级) 的重要性,并探索了推理.
- 两位独立研究人员对采访成绩单进行了主题分析.
主要成果:
- 19个利益相关者参加了会议,代表了各种角色和环境.
- "诊断结果的更广泛影响" (例如,确定额外的治疗方法) 被高度评价,与临床益处和成本一起.
- 在实验室组织方面出现了差异,学术中心倾向于集中,非学术中心倾向于去中心化.
结论:
- "诊断结果的更广泛影响",可行性和测试过程是CGP采用的关键考虑因素,以及临床益处和成本.
- 了解利益相关者的异质性,特别是关于他们的原始环境,对于政策决策至关重要.
- 这些发现为针对性分析的全面技术评估提供了信息,而不是CGP.
更多相关视频
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
相关概念视频
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Genomics
Cancer Prevention
Some...
Cancer Survival Analysis
